The global breast imaging market is expected to reach USD 4.14 Billion by 2021 from USD 2.76 Billion in 2016, at a CAGR of 8.5%.

Browse 107 market data Tables and 39 Figures spread through 150 Pages and in-depth TOC on "Breast Imaging Market by Type (Ionizing Technologies (Mammography, Digital Mammography, 3D Mammography, MBI, PET-CT, CBCT, PEM) Non-ionizing Technologies (Breast MRI, Breast Ultrasound, AWBU, Breast Thermography, Optical Imaging)) - Forecast to 2021"
http://www.marketsandmarkets.com/Market-Reports/breast-imaging-technologies-market-897.html

Objectives of the study:

To define, describe, and forecast the breast imaging market on the basis of type
To provide detailed information regarding major factors influencing growth of the market (drivers, restraints, opportunities, and industry-specific challenges)
To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
To forecast revenue of the market segments with respect to four regions, namely, North America, Europe, Asia-Pacific, and the Rest of the World
To strategically profile the key players and comprehensively analyze their market shares and core competencies2
To track and analyze competitive developments such as new product launches and product enhancements; agreements, partnerships, and collaborations; mergers and acquisitions; and R&D activities in the breast imaging market

Both, top-down and bottom-up approaches were used to estimate and validate the size of the global market and to estimate the size of various other dependent submarkets in the overall breast imaging market. The research study involved extensive use of secondary sources; such as, Bloomberg Business, Factiva, government databases, American Cancer Society, U.S. Food and Drug Administration, World Bank, GLOBOCAN 2012, International Agency for Research on Cancer (IARC); and MarketsandMarkets Analysis. In-depth interviews were conducted to obtain and verify critical qualitative and quantitative information as well as assess prospects.

As of 2015, Hologic, Inc. (U.S.), GE Healthcare (U.K.), Siemens Healthcare (Germany), Philips Healthcare (Netherlands), and Fujifilm Holdings Corporation (Japan) holds the leading position in the breast imaging market. These companies adopted product launches, agreements, and partnerships as their business strategies to ensure their market position. Gamma Medica, Inc. (U.S.), Toshiba Corporation (Japan), Sonocine, Inc. (U.S.), Aurora Imaging Technology, Inc. (U.S.), and Dilon Technologies, Inc. (U.S.) are some of the other major players in this market.